The Epidemiological Transition

The epidemiological transition runs alongside the demographic transition and explains why the death rate falls the way it does. In poor, low-stage countries, people mostly die young from infectious and parasitic disease: diarrheal illness, malaria, childhood infections. These spread fast where sanitation is weak and vaccines are scarce, and they kill before anyone gets old enough to develop cancer or heart disease. As a country develops, clean water, sewage systems, vaccination, and basic medical care cut infectious deaths sharply. That does not just lower the death rate. It changes what the death rate is made of.

Once people stop dying young from infection, they live long enough for diseases that take decades to build up, heart disease, stroke, cancer, diabetes, to become the dominant killers. This is the stage historians call the age of degenerative and human-made disease, and it matches the later stages of the demographic transition where death rates are low and stay low. The transition is usually described in stages: pandemics of infection and famine, receding pandemics, degenerative and human-made disease, and a proposed fourth stage of delayed degenerative disease where medical advances stretch out life even further. Some add a fifth stage for reemerging infectious disease.

The transition is not guaranteed to be permanent or one-directional. A disease like tuberculosis, once pushed down by antibiotics, can reemerge in a drug-resistant form and climb back up the list of causes of death even in a country that had fully shifted to chronic disease. HIV/AIDS did something similar in parts of Africa. That reversal is why the model matters for reading the demographic transition: it explains the mechanism behind the death-rate drop, not just the fact of it.